Moteur de recherche d’entreprises européennes

UK funding (173 790 £) : 3D-DIP-ChIP : une méthode « omique » pour mesurer les dommages à l’ADN induits par la génotoxine Ukri01/10/2014 UK Research and Innovation, Royaume Uni

Vue d’ensemble

Texte

3D-DIP-ChIP : une méthode « omique » pour mesurer les dommages à l’ADN induits par la génotoxine

Abstract Industries across a broad spectrum of sectors are now generating increasing numbers of innovative and novel compounds and products, which have the potential to bring enormous benefits to society. Many of these novel compounds will become incorporated into products that will bring continued economic growth and improve global living standards. However, the safe introduction and release of these new materials into the world requires safety assessment prior to their use. At the moment, many of the methods employed to do this were developed in the middle of the last century, and rely heavily on the use of animals. It has become increasingly clear that these methods have limitations, including their speed, scale of use, accuracy and predictivity of various outcomes and relevance to the human context. There is now a concerted global effort to develop novel non-animal methods that will more quickly and accurately predict the safety of novel compounds being produced. The work described in this project will evaluate the potential of a novel method developed in the UK using genomic technology to be used in the assessment of novel materials.
Category Feasibility Studies
Reference 131733
Status Closed
Funded period start 01/10/2014
Funded period end 30/09/2015
Funded value £173 790,00
Source https://gtr.ukri.org/projects?ref=131733

Participating Organisations

UNILEVER U.K. CENTRAL RESOURCES LIMITED

£69 461,00

CARDIFF UNIVERSITY

£104 329,00

Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : Unilever U.K. Central Resources Ltd., Londres, Royaume Uni.